Evonik Venture Capital

What is Evonik Venture Capital?

Evonik Venture Capital (EVC) is the Corporate Venture Capital arm of Evonik Industries, playing a strategic role in achieving the goal of developing Evonik into a best-in-class specialty chemicals company.

With headquarters in Hanau, Hessen, Germany, EVC functions by investing in promising start-ups that complement Evonik's robust product portfolio and drive innovation in specialty chemicals. They actively seek partnerships with emerging companies that are engaged in highly attractive markets exhibiting above-average growth rates.

EVC focuses its investments on areas aligning with Evonik's strategic growth areas: Advance Precision Biosolutions, Accelerate Energy Transition, and Enable Circular Economy. These growth areas indicate their commitment to advancing biosolutions precision, accelerating the transition to sustainable energy, and fostering practices that contribute to the circular economy.

EVC's investment approach is not limited to financial support; they are looking at making strategic investments that could provide synergies with Evonik’s business and technological expertise fostering mutual growth.

Their portfolio features a diverse selection of innovative companies, such as Abolis Biotechnologies that aims for sustainable solutions across various industries including food and health, Interface Polymers which innovates in the field of plastic processing and recycling, and SuperC, a company enhancing lithium-ion batteries for electromobility.

Furthermore, their interest in pain management solutions post-surgery is evident through their investment in Allay Therapeutics. EVC has also expanded its global footprint by investing in a Japanese venture capital company, indicating a commitment to diversification and international collaboration. Additionally, EVC has invested in sustainability-focused funds like Azolla Ventures and Chrysalix Venture Capital's Carbon Neutrality Fund, demonstrating a clear dedication to environmental sustainability and responsible corporate stewardship.

Moreover, the partnership with Jland Biotech to market vegan collagen for cosmetics shows EVC’s interest in innovative and sustainable consumer products.